Article
The phe-124-Cys and A-161T variants of the human 5-HT1B receptor gene are not major determinants of the clinical response to sumatriptan.
Headache - 1 May 2007
Mehrotra Suneet, Vanmolkot Kaate R J, Frants Rune R, van den Maagdenberg Arn M J M, Ferrari Michel D, MaassenVanDenBrink Antoinette
Abstract excerpt
BACKGROUND: The 5-HT(1B/1D) receptor agonist sumatriptan is highly effective in the treatment of migraine. However, some patients do not respond to sumatriptan or experience recurrence of the headache after initial relief. In addition, some patients report chest symptoms after the use of sumatrip...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
